Clik here to view.
The Big Pivot
Pivot Point by HystericalMark The President’s address fell mainly in line with what he’s been saying over the past several weeks: with the debt limit deal, a “manufactured crisis” in his words, put to...
View ArticleClik here to view.
US Political System Gets Downgraded, Failure to Deal With Economy the Reason
Moody’s has joined Fitch in declining to downgrade the US credit rating after passage of the debt limit deal, though they still have the US on a negative outlook. This means Standard and Poor’s can...
View ArticleClik here to view.
White House Has Several Unused Options When It Comes to Jobs
(photo: GoTrisi) As Dick Polman writes today, the Obama Administration put themselves in a box on jobs that will be difficult to emerge from. While the spending cuts in the near term are not all that...
View ArticleClik here to view.
Obama Administration Plans Round of Trans-Pacific Free Trade Agreement Talks
Jon Huntsman’s economic plan should dispel any rumors of his moderation. It eliminates the Earned Income Tax and the child tax credit to pay for a reduction of the top marginal tax rate to 23%. I don’t...
View ArticleClik here to view.
Congress Returns to Session Amid High Negatives and Much Despair
Congress is back on the job today, at least in the Senate. The House just had to have one more day off to refresh them for the ideological agenda-setting ahead. The return to session comes at a time...
View ArticleClik here to view.
Patent Reform’s Done, So Let the Job Valhalla Commence!
In a way, I’m not sure why the President made a jobs speech to Congress yesterday at all. Clearly all of our job worries have been solved with the passage of a patent reform bill: As expected, the U.S....
View ArticleClik here to view.
Apple-Samsung Trial: Another Loss for Consumers
By way of disclosure, let me say that I own a Samsung Galaxy II and I love it. But others may not get the same opportunity after Apple won a $1.05 billion verdict in what was described in technology...
View ArticleClik here to view.
Novartis Ruling In India Could Spark Larger Movement Against Patent Trolling
Gleevec So let’s say you are a leading multinational pharmaceutical company and you have a blockbuster cancer drug. You patent the drug, make tremendous profits, but now the clock is ticking and the...
View Article
